| Literature DB >> 20334689 |
Shi-Rui Gan1, Sheng-Sheng Shi, Jian-Jun Wu, Ning Wang, Gui-Xian Zhao, Sheng-Tong Weng, Shen-Xing Murong, Chuan-Zhen Lu, Zhi-Ying Wu.
Abstract
BACKGROUND: Machado-Joseph disease (MJD), caused by a CAG repeat expansion located in exon10 of the ATXN3 gene, is now regarded as one of the most common spinocerebellar ataxia (SCA) in the world. The relative frequency of MJD among SCA has previously been estimated at about 50% in the Chinese population and has been reported to be related to the frequency of large normal alleles in some populations. Taq polymerase has been used for PCR in nearly all studies reported previously.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20334689 PMCID: PMC2861663 DOI: 10.1186/1471-2350-11-47
Source DB: PubMed Journal: BMC Med Genet ISSN: 1471-2350 Impact factor: 2.103
Figure 1Distribution of the SCA families in the present study. The numbers in parentheses indicate numbers of MJD families/numbers of SCA families. (Reproduced with permission from http://nfgis.nsdi.gov.cn)
Figure 2Distribution of the CAG repeats in 300 ANs from 150 healthy Chinese individuals. The numbers upon the column indicate the number of allele.
Figure 3The polyacrylamide gel electrophoresis analysis of ANs (A) and alleles of SCA patients (B). In figure 2A, lanes 1-5 were normal individuals. The black line indicates the upper limit of ANs. In figure 2B, lanes 1, 3, 4, and 5 were MJD patients; lane 2 was an SCA patient, but not a MJD patient. The black line indicates the place of the lower limit of expanded alleles. M: pGEM-3Zf (+) DNA-Hae III marker.
Figure 4Chromatograms of the AN with 14 CAG (A) and the expanded allele with 81 CAG (B).
The frequencies of large normal alleles of ATXN3 gene
| Number of CAG repeats | Present study | Japanese | Indian | Czech | Combined Population | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Frequency | Frequency | χ2 | P | Frequency | χ2 | P | Frequency | χ2 | P | Frequency | χ2 | P | |
| >27 | 0.28 | 0.21 | 3.683 | 0.055 | 0.12 | 42.045 | 0.000 | 0.09 | 27.663 | 0.000 | 0.17 | 8.616 | 0.003 |
| >28 | 0.19 | 0.11 | 6.788 | 0.009 | 0.08 | 29.060 | 0.000 | 0.04 | 21.956 | 0.000 | 0.11 | 10.341 | 0.001 |
| >29 | 0.13 | 0.07 | 5.869 | 0.015 | 0.04 | 28.517 | 0.000 | 0.04 | 11.836 | 0.001 | 0.08 | 5.264 | 0.002 |
| >30 | 0.10 | 0.05 | 4.342 | 0.037 | 0.03 | 22.329 | 0.000 | 0.03 | 8.499 | 0.004 | 0.07 | 3.192 | 0.074 |
| >31 | 0.07 | 0.05 | 1.332 | 0.248 | 0.02 | 14.120 | 0.000 | 0.01 | 8.186 | 0.004 | 0.05 | 2.190 | 0.139 |
Frequencies of MJD in SCA patients from different Asia populations
| Number of MJD | Number of SCA | Frequency (%) | P | Reference | |
|---|---|---|---|---|---|
| Chinese mainland | 59 | 120 | 49.2 | <0.001 | 23 |
| 41 | 85 | 48.2 | <0.001 | 24 | |
| 26 | 75 | 34.7 | <0.001 | 25 | |
| 1 | 8 | 12.5 | <0.001 | 22 | |
| Chinese Taiwan | 35 | 74 | 47.3 | <0.001 | 26 |
| 26 | 81 | 32.1 | <0.001 | 27 | |
| Singapore | 15 | 36 | 41.7 | 0.001 | 28 |
| Japan | 87 | 202 | 43.1 | <0.001 | 9 |
| 12 | 29 | 41.4 | 0.001 | 29 | |
| 91 | 330 | 27.6 | <0.001 | 30 | |
| 30 | 113 | 26.5 | <0.001 | 31 | |
| 35 | 143 | 24.5 | <0.001 | 32 | |
| 28 | 117 | 23.9 | <0.001 | 33 | |
| 8 | 46 | 17.4 | <0.001 | 34 | |
| 3 | 86 | 3.5 | <0.001 | 35 | |
| Thailand | 35 | 182# | 19.2 | <0.001 | 36 |
| Korea | 4 | 40 | 10.0 | <0.001 | 37 |
| 13 | 237 | 5.5 | <0.001 | 38 | |
| India | 5 | 14 | 35.7 | 0.005 | 39 |
| 15 | 105 | 14.3 | <0.001 | 40 | |
| 2 | 39 | 5.1 | <0.001 | 12 | |
| 7 | 143 | 4.9 | <0.001 | 10 | |
| 1 | 32 | 3.1 | <0.001 | 41 | |
| 2 | 77 | 2.6 | <0.001 | 42 | |
| 0 | 28 | 0 | <0.001 | 43 | |
# composed of patients with dominant SCA and sporadic ataxia
Frequencies of MJD in SCA patients from various countries
| Countries | Number of MJD | Number of SCA | Frequency (%) | Reference |
|---|---|---|---|---|
| Portugal | 32 | 38 | 84.2 | 16 |
| Brazil | 96 | 114 | 84.2 | 17 |
| Portugal/Brazil | 67 | 106 | 63.2 | 44 |
| Germany | 32 | 77 | 41.6 | 45 |
| France | 25 | 87 | 28.7 | 46 |
| Holland | 64 | 227 | 28.2 | 47 |
| America* | 31 | 149 | 20.8 | 48 |
| Spain | 11 | 72 | 15.3 | 49 |
| Australia | 11 | 88 | 12.5 | 13 |
| Mexico | 13 | 108 | 12.0 | 50 |
| South Africa | 2 | 54 | 3.7 | 51 |
| Italy | 2 | 183 | 1.1 | 52 |
| UK | 0 | 22 | 0 | 53 |
| Serbia | 0 | 38 | 0 | 54 |
| Finland | 0 | 49 | 0 | 55 |
| Norway | 0 | 19 | 0 | 56 |
| Czech | 0 | 118# | 0 | 11 |
| Combined | 486 | 1687 | 28.8 |
*The patient subjects mixed with African American, Caucasian American, Cambodian, Japanese, Pakistani, Lebanese and Peruvian; # composed of patients with dominant SCA and sporadic ataxia
Figure 5The agarose gel electrophoresis analysis of alleles of MJD patients. Lanes 1-12 were all MJD patients and were the same patients in A and B. A: The alleles were amplified with Taq polymerase. B: The alleles were amplified with LA Taq polymerase. M: DL2000 marker.